Polyspecific malaria antibodies present at the time of infection inhibit the development of immunity to malaria but antibodies specific for the malaria merozoite surface protein, MSP1, facilitate immunity

Parasite Immunology

Volumn 24, Issue 5, 2002, Pages 233-241

  Zhang, Wenbao ^a   Liu, Xue Qin ^a   Xu, Huji ^a   Good, Michael F ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Immune regulation; Mouse; Plasmodium yoelii; Vaccines

Indexed keywords

MEROZOITE SURFACE PROTEIN 1; PROTOZOON ANTIBODY; PYRIMETHAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNITY; IMMUNOREGULATION; INFECTION RESISTANCE; MALARIA; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLASMODIUM YOELII; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; IMMUNE SERA; IMMUNITY, CELLULAR; IMMUNIZATION, PASSIVE; MALARIA; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII; PROTOZOAN VACCINES; TIME FACTORS; VACCINES, SYNTHETIC;

ANIMALIA; PLASMODIUM YOELII; PROTOZOA;

EID: 0036277715     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2002.00456.x     Document Type: Article

References (24)

1. Antigens induced on erythrocytes by P. falciparum: Expression of diverse and conserved determinants
2. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria
3. Pathways and strategies for developing a malaria blood-stage vaccine
4. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malaria parasite, Plasmodium chabaudi adami
5. The role of Th1 and Th2 cells in a rodent malaria infection
6. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice
7. Gamma-globulin and acquired immunity to human malaria
8. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria
9. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1
10. Passive immunization against malaria with an IgG3 monoclonal antibody
11. Immunization against malaria with a recombinant protein
12. + T cells adoptively transferred into recipient mice after challenge with homologous parasite
13. 19) of Plasmodium yoelii expressed in Saccharomyces cerevisiae
14. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines
15. An indirect asymmetrical sandwich ELISA using anti-allotype antibodies for the specific and quantitative measurement of mouse IgG2a of Igh-1b allotype
16. Regulation of B-cell activation and antigen presentation by Fc receptors
17. Results of clinical trials of RhoGAM in women
18. High incidence of asymptomatic malaria infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction
19. The real difficulties for malaria sporozoite vaccine development. Nonresponsiveness and antigenic variation
20. 'Original antigenic sin', T cell memory, and malaria sporozoite immunity: An hypothesis for immune evasion
21. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting
22. The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens
23. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine